Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

HK Type 4 license through Ballingal Investment Advisors Ltd. 

I'm a highly experienced sell-side analyst with in excess of 22 years of covering Asia Pacific equities, the past 19 years immersed in event strategies encompassing M&A risk arbitrage, directional long/short, stub trades and restructuring.  

My background also includes accountancy (liquidation/bankruptcy/receivership) earlier in my career and as a chief financial officer of a global commodity company based in the US and Mexico.

Pan-Asia Catalysts/Events

Yichang HEC (1558 HK): Absorption Via Speculative Scrip. Avoid

Quiddity Advisors

Event-Driven

Yichang HEC Changjiang Pharma / Event-Driven

<ul>
<li>A little over a year ago, I wrote about <a href="https://www.smartkarma.com/entities/yichang-hec-changjiang-pharmaceutical" target="_blank" data-smartkarma-citation="entities:21040:1" rel="noopener">Yichang HEC Changjiang Pharma (1558 HK)</a>'s overly complicated scrip Offer in <a href="https://skr.ma/RSCyX" target="_blank" rel="noopener">Yichang HEC (1558 HK): Absorption Via Speculative Scrip. Avoid</a>.</li>
<li>In summary, Yichang HEC shareholders were being offered 0.263614 "Offeror H shares". These consideration shares are unlisted. The Offeror being Yichang HEC's controlling shareholder (51.41%).</li>
<li>
The Composite Doc and the Offeror's Listing by Way Of Introduction Doc are out.  The independent H-shareholder vote is the 21st July. Shareholders should vote this down.</li>
</ul>


A little over a year ago, I wrote about Yichang HEC Changjiang Pharma (1558 HK)'s overly complicated scrip Offer in Yichang HEC (1558 HK): Absorption Via Speculative Scrip. Avoid.
In summary, Yichang HEC shareholders were being offered 0.263614 "Offeror H shares". These consideration shares are unlisted. The Offeror being Yichang HEC's controlling shareholder (51.41%).

The Composite Doc and the Offeror's Listing by Way Of Introduction Doc are out.  The independent H-shareholder vote is the 21st July. Shareholders should vote this down.


Yichang HEC (1558 HK): Speculative Scrip Offer? No Thanks - Vote No